Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Fibroblast Growth Factor 7 × Clear all

NCT00540332 2009-03-02

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Phase 1/2 Withdrawn

Head and Neck Neoplasms, Neoplasms, Stomatitis